Chromosome 1p allelic loss by fluorescence in situ hybridization is not observed in dysembryoplastic neuroepithelial tumors

American Journal of Clinical Pathology

Volumn 118, Issue 4, 2002, Pages 512-517

  Prayson, Richard A ^a   Castilla, Elias A ^a   Hartke, Marybeth ^a   Pettay, James ^a   Tubbs, Raymond R ^a   Barnett, Gene H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chromosome 1; Chromosome marker; Dysembryoplastic neuroepithelial tumor; Oligodendroglioma

Indexed keywords

ADULT; ARTICLE; CHROMOSOME 1P; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HETEROZYGOSITY LOSS; HUMAN; MALE; NEUROEPITHELIOMA; OLIGODENDROGLIOMA; PRIORITY JOURNAL; ADOLESCENT; BRAIN TUMOR; CHILD; CHROMOSOME 1; GENETICS; MIDDLE AGED; PATHOLOGY; TERATOMA;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CHILD; CHROMOSOMES, HUMAN, PAIR 1; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NEOPLASMS, NEUROEPITHELIAL; OLIGODENDROGLIOMA; TERATOMA;

EID: 0036780748     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/KLAG-TARW-WDBJ-5CTJ     Document Type: Article

References (31)

1. Daumas-Duport C, Scheithauer BW, Chodkiewicz J-P, et al. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures: report of thirty-nine cases. Neurosurgery. 1988;23:545-556.
2. Daumas-Duport C, Pietsch T, Lantos PL. Dysembryoplastic neuroepithelial tumour. In: Kleihues P, Cavenee WK, eds. Tumours of the Nervous System. Lyon, France: IARC Press; 2000:103-106.
3. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst. 1998;90:1473-1479.
4. Smith JS, Perry A, Borell TJ, et al. Alterations of chromosome 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligodendrocytomas. J Clin Oncol. 2000;18:636-645.
5. Ino Y, Zlatescu MC, Sasaki H, et al. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. J Neurosurg. 2000;92:983-990.
6. Zlatescu MC, Tehrani Yaidi A, Sasaki H, et al. Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res. 2001;61:6713-6715.
7. Burger PC, Minn AY, Smith JS, et al. Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma: a study of paraffin-embedded sections. Mod Pathol. 2001;14:842-853.
8. Caskey LS, Fuller GN, Bruner JM, et al. Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling. Histol Histopathol. 2000;15:971-981.
9. Ino Y, Betensky RA, Zlatescu MC, et al. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res. 2001;7:839-845.
10. Bauman GS, Ino Y, Ueki K, et al. Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. Im J Radiat Oncol Biol Phys. 2000;43:825-830.
11. Raymond AA, Halpin FS, Alsanjari N, et al. Dysembryoplastic neuroepithelial tumour: features in 16 patients. Brain. 1994;117:451-475.
12. Taratuto AL, Pomata H, Sevlever G, et al. Dysembryoplastic neuroepithelial tumor: morphological, immunocytochemical, and deoxyribonucleic acid analyses in a pediatric series. Neurosurgery. 1995;36:474-481.
13. Prayson RA, Estes ML. Dysembryoplastic neuroepithelial tumor. Am J Clin Pathol. 1992;97:398-401.
14. Raymond AA, Fish DR, Sisodiya SM, et al. Abnormalities of gyration, heterotopias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dysembryoplastic neuroepithelial tumour and dysgenesis of the archicortex in epilepsy: clinical, EEG and neuroimaging features in 100 adult patients. Brain. 1995;118:629-660.
15. Daumas-Duport C. Dysembryoplastic neuroepithelial tumours. Brain Pathol. 1993;3:283-295.
16. Honavar M, Janota I, Polkey CE. Histological heterogeneity of dysembryoplastic neuroepithelial tumour: identification and differential diagnosis in a series of 74 cases. Histopathology. 1999;34:342-356.
17. Prayson RA, Morris HH, Estes ML, et al. Dysembryoplastic neuroepithelial tumor: a clinicopathologic and immunohistochemical study of 11 tumors including MIB1 immunoreactivity. Clin Neuropathol. 1996;15:47-53.
18. Leung SY, Gwi E, Ng HK, et al. Dysembryoplastic neuroepithelial tumor: a tumor with small neuronal cells resembling oligodendroglioma. Am J Surg Pathol. 1994;18:604-614.
19. Hirose T, Scheithauer BW, Lopes BS, et al. Dysembryoplastic neuroepithelial tumor (DNT): an immunohistochemical and ultrastructural study. J Neuropathol Exp Neurol. 1994;53:184-195.
20. Wolf HK, Buslei R, Blumcke I, et al. Neural antigens in oligodendrogliomas and dysembryoplastic neuroepithelial tumors. Acta Neuropathol. 1997;94:436-443.
21. Gyure KA, Sandberg GD, Prayson RA, et al. Dysembryoplastic neuroepithelial tumor: an immunohistochemical study with myelin oligodendrocyte glycoprotein. Arch Pathol Lab Med. 2000;124:123-126.
22. Prayson RA, Estes ML, Morris HH. Coexistence of neoplasia and cortical dysplasia in patients presenting with seizures. Epilepsia. 1993;34:609-615.
23. Perry A. Oligodendroglial neoplasms: current concepts, misconceptions and folklore. Adv Anat Pathol. 2001;8:183-199.
24. Bigner SH, Rasheed BKA, Wiltshire R, et al. Morphologic molecular genetic aspects of oligodendroglial neoplasms. Neuro-oncol. 1999;1:52-60.
25. Smith JS, Alderete B, Minn Y, et al. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene. 1999;18:4144-4152.
26. Reifenberger J, Reifenberger G, Liu L, et al. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol. 1994;145:1175-1190.
27. Bello MJ, Leone PE, Vaquero J, et al. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int J Cancer. 1995;64:207-210.
28. Kraus JA, Koopmann J, Kaskel P, et al. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol. 1995;54:91-95.
29. Bigner SH, Matthews MR, Rasheed BKA, et al. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol. 1999;155:375-386.
30. Ritland SR, Ganju V, Jenkins RB. Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chromosomes Cancer. 1995;12:277-282.
31. Balani JP, Margraf L, Perry A, et al. Pediatric oligodendrogliomas: molecular characteristics [abstract]. Mod Pathol. 2002;15:298A.